Accelerating Drug Discovery

“The R2M team worked with Tenaya to accelerate lead optimization in our small molecule drug development programs.  R2M was a great resource for us a start-up biotech company without internal medicinal chemistry expertise. They supported target validation, compound optimization, DMPK and patent strategy needs in a very professional and efficient manner.  R2M has an experienced, productive, and results-oriented team and are great to work with.”

Timothy Hoey, Ph.D.

Chief Scientific Officer

Tenaya Therapeutics, Inc.